H
HIF-1α
Full name: Hypoxia-Inducible Factor 1-alpha
A transcription factor that regulates cellular response to oxygen availability. HBOT paradoxically stabilises HIF-1α (via oxidative stress signalling), driving downstream angiogenesis, stem cell mobilisation, and tissue repair. A central mechanism in HBOT biology.
About HIF-1α
This HBOT Hub glossary entry covers Hypoxia-Inducible Factor 1-alpha as a term used in hyperbaric oxygen therapy — its definition, clinical significance, and relevance across treatment protocols, chamber types, and research applications. Browse the full HBOT A–Z glossary for related terminology, or see our research library for context on how this concept appears in the HBOT literature.
Explore Related HBOT Topics
- Hyperbaric chamber types — monoplace, multiplace, hard-shell, soft-shell, and portable chamber specifications.
- HBOT conditions and indications — evidence-based reference across 20+ indications.
- Treatment protocols — pressure levels (1.3–2.8 ATA) and course schedules by indication.
- Research library — peer-reviewed evidence base organised by evidence tier.
- Safety guidelines — contraindications, screening, and in-chamber safety practice.
- Regulatory status — UHMS indications, FDA clearances, and CMS reimbursement.